OXFORD, England--(BUSINESS WIRE)--Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, today announced the closing of a $9.6M seed financing round led by Khosla Ventures, ...
Biotechnology startup Ochre Bio Ltd. has landed $9.6 million in seed financing on the strength of RNA technology that could make liver transplants more successful for some patients. Liver transplants ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback